Cargando…
Advanced diffusion magnetic resonance imaging in patients with Alzheimer's and Parkinson's diseases
The prevalence of neurodegenerative diseases is increasing as human longevity increases. The objective biomarkers that enable the staging and early diagnosis of neurodegenerative diseases are eagerly anticipated. It has recently become possible to determine pathological changes in the brain without...
Autores principales: | Kamagata, Koji, Andica, Christina, Hatano, Taku, Ogawa, Takashi, Takeshige-Amano, Haruka, Ogaki, Kotaro, Akashi, Toshiaki, Hagiwara, Akifumi, Fujita, Shohei, Aoki, Shigeki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7437577/ https://www.ncbi.nlm.nih.gov/pubmed/32209758 http://dx.doi.org/10.4103/1673-5374.276326 |
Ejemplares similares
-
Diffusion Magnetic Resonance Imaging-Based Biomarkers for Neurodegenerative Diseases
por: Kamagata, Koji, et al.
Publicado: (2021) -
Brain White-Matter Degeneration Due to Aging and Parkinson Disease as Revealed by Double Diffusion Encoding
por: Kamiya, Kouhei, et al.
Publicado: (2020) -
Fiber-specific white matter alterations in early-stage tremor-dominant Parkinson’s disease
por: Andica, Christina, et al.
Publicado: (2021) -
Parkinson’s disease: deep learning with a parameter-weighted structural connectome matrix for diagnosis and neural circuit disorder investigation
por: Yasaka, Koichiro, et al.
Publicado: (2021) -
MR Biomarkers of Degenerative Brain Disorders Derived From Diffusion Imaging
por: Andica, Christina, et al.
Publicado: (2019)